EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Bromodomain‐Containing Protein 4 in Ischemia‐Reperfusion Injury: Mechanisms, Preclinical Evidence, and Translational Challenges

Namrata Vadak iD, Lokesh Kumar Bhatt iD

Cell Biology International · 2026-10 · 50 (10)

DOI: 10.1002/cbin.70223 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell Biology International, online erschienen am 14.10.2026. Verfasst von Namrata Vadak und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, Mumbai, India. Hauptthemen laut MEDLINE: Reperfusion Injury, Transcription Factors, Cell Cycle Proteins, Nuclear Proteins. Die Arbeit nennt 135 Literaturangaben. Gefördert von: Department of Science and Technology (DST).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ischemia reperfusion (IR) injury is a major contributor to tissue damage and organ dysfunction following ischemic events and clinical interventions such as thrombolysis, revascularization, and transplantation, yet effective pharmacological strategies to limit this injury remain limited. Bromodomain‐containing protein 4 (BRD4), an epigenetic reader that recognizes acetylated lysine residues to drive super‐enhancer‐associated transcription. Upregulated BRD4 has emerged as a key regulator of the inflammatory, endothelial, and cell death pathways underlying post‐IR injury pathophysiology. Preclinical evidence across cerebral, cardiac, renal, and hepatic IR injury models indicates that BRD4 hyperactivation amplifies NFκB‐dependent inflammatory signaling, while its pharmacological or genetic inhibition confers substantial tissue protection. This review synthesizes current mechanistic understanding of BRD4 in IR injury pathogenesis, evaluates emerging BET/BRD4‐targeted therapeutic strategies, and outlines key translational challenges for advancing epigenetic pharmacology toward clinical application in IR‐associated disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reperfusion InjuryTranscription FactorsCell Cycle ProteinsNuclear ProteinsHumansBromodomain Containing ProteinsAnimalsEpigenesis, GeneticSignal Transduction

Stichwörter der Autor:innen

BRD4 inhibitorsJQ1bromodomain‐containing protein 4epigeneticischemia reperfusion injury

Substanzen

Bromodomain Containing ProteinsTranscription FactorsBRD4 protein, humanCell Cycle ProteinsNuclear Proteins

Autor:innen und Institutionen

  • Department of Pharmacology, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, Mumbai, India.

ORCID-Profile: Namrata Vadak, Lokesh Kumar Bhatt

Förderung

  • Department of Science and Technology (DST)

Zitieren

APA

Vadak, N., & Bhatt, L. K. (2026). Bromodomain‐Containing Protein 4 in Ischemia‐Reperfusion Injury: Mechanisms, Preclinical Evidence, and Translational Challenges. Cell Biology International, 50(10). https://doi.org/10.1002/cbin.70223

Vancouver

Vadak N, Bhatt LK. Bromodomain‐Containing Protein 4 in Ischemia‐Reperfusion Injury: Mechanisms, Preclinical Evidence, and Translational Challenges. Cell Biology International. 2026;50(10). doi:10.1002/cbin.70223

BibTeX
@article{Vadak2026,
  author = {Vadak, Namrata and Bhatt, Lokesh Kumar},
  title = {Bromodomain‐Containing Protein 4 in Ischemia‐Reperfusion Injury: Mechanisms, Preclinical Evidence, and Translational Challenges},
  journal = {Cell Biology International},
  year = {2026},
  volume = {50},
  number = {10},
  doi = {10.1002/cbin.70223}
}
Kostenlos starten →